Varenicline

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,630 citations

Shape of the relapse curve and long‐term abstinence among untreated smokers

2003 • 1,364 citations

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,343 citations

Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 1997–2001

2007 • 1,337 citations

Antidepressants for smoking cessation

2020 • 1,245 citations

Effect of Maintenance Therapy With Varenicline on Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 664 citations

Cost-effectiveness of the Clinical Practice Recommendations in the AHCPR Guideline for Smoking Cessation

1997 • 473 citations

Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist

2006 • 392 citations

Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation

2006 • 380 citations

Smoking and Smoking Cessation in Relation to Mortality in Women

2008 • 372 citations

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

2008 • 338 citations

Smoking vs Other Risk Factors as the Cause of Smoking-Attributable Deaths

2000 • 315 citations

Fitness-related activities and medical claims related to hospital admissions - South Africa, 2006.

2009 • 296 citations

The problem of tobacco smoking

2004 • 289 citations

Nicotine replacement therapy for smoking cessation

2001 • 280 citations

Intensive Smoking Cessation Intervention Reduces Mortality in High-Risk Smokers With Cardiovascular Disease

2007 • 275 citations

Regional, disease specific patterns of smoking-attributable mortality in 2000

2004 • 219 citations

Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

2007 • 217 citations

Healthcare financing systems for increasing the use of tobacco dependence treatment

2017 • 209 citations

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database

2009 • 202 citations

Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers

2007 • 194 citations

Counseling and Interventions to Prevent Tobacco Use and Tobacco-Caused Disease in Adults and Pregnant Women: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement

2009 • 176 citations

The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation

2002 • 174 citations

The burden of smoking-related ill health in the UK

2009 • 148 citations

Smoking relapse after 2 years of abstinence: findings from the VA Normative Aging Study

2002 • 148 citations

A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers

2007 • 137 citations

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial

2008 • 113 citations

Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis.

2008 • 112 citations

Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model

2008 • 96 citations

Advances in pharmacotherapy for tobacco dependence

2004 • 94 citations

Late relapse/sustained abstinence among former smokers: a longitudinal study

2004 • 92 citations

Varenicline Versus Bupropion SR or Placebo for Smoking Cessation: A Pooled Analysis

2008 • 90 citations

Advances in pharmacotherapy for tobacco dependence

2004 • 90 citations

Varenicline for smoking cessation: A placebo‐controlled, randomized study

2009 • 89 citations

Efficacy and Safety of Varenicline for Smoking Cessation

2008 • 87 citations

Development of the health and economic consequences of smoking interactive model

2001 • 75 citations

A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation

2009 • 74 citations

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands

2007 • 72 citations

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England

2009 • 72 citations

The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model

2009 • 57 citations

Varenicline

2006 • 54 citations

Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation—results from four European countries

2009 • 48 citations

An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation

2007 • 45 citations

Varenicline as compared to bupropion in smoking-cessation therapy—Cost–utility results for Sweden 2003

2008 • 44 citations

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation

2009 • 42 citations

A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence

2006 • 41 citations

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

2009 • 37 citations

Tobacco smoking cessation management: integrating varenicline in current practice

2008 • 36 citations

Encouraging Smokers to Quit

2006 • 33 citations

Safety and Effectiveness of Varenicline in a Veteran Population with a High Prevalence of Mental Illness

2009 • 33 citations

Smoking Cessation: An Overview of Treatment Options with a Focus on Varenicline

2007 • 30 citations

Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers

2010 • 30 citations

Smoking‐cessation therapy using varenicline: the cost‐utility of an additional 12‐week course of varenicline for the maintenance of smoking abstinence

2009 • 29 citations

State-level Medicaid expenditures attributable to smoking.

2009 • 29 citations

Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch

1997 • 28 citations

Worsening Psychosis Induced by Varenicline in a Hospitalized Psychiatric Patient

2009 • 28 citations

Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countries

2009 • 27 citations

The effectiveness of nationally implemented smoking interventions in Denmark

2007 • 23 citations

Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression

2008 • 23 citations

Análisis coste-efectividad de vareniclina (Champix®) en el tratamiento del tabaquismo en España

2008 • 22 citations

Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?

2009 • 20 citations

Varenicline Gets Stronger Warnings About Psychiatric Problems, Vehicle Crashes

2009 • 18 citations

The cost effectiveness of varenicline for smoking cessation.

2007 • 16 citations

Current and future avoidable cost of smoking – Estimates for Sweden 2007

2011 • 16 citations

Budgetary Impact of Varenicline in Smoking Cessation in the United Kingdom

2008 • 12 citations

Suicidal Ideation and Varenicline

2008 • 9 citations

Cost–effectiveness of varenicline for smoking cessation

2009 • 8 citations

PRS16 AN ECONOMIC EVALUATION OF A PHARMACOLOGICAL INTERVENTION USING VARENICLINE AS THERAPY FOR SMOKING CESSATION

2009 • 3 citations

Análisis coste-efectividad de vareniclina (Champix®) frente a los parches de nicotina en el tratamiento del tabaquismo en México

2009 • 3 citations

Cited By (0)

Loading...